A Study Utilizing Imaging Techniques and Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

July 22, 2020

Study Completion Date

December 21, 2020

Conditions
Knee Osteoarthritis
Interventions
DRUG

SM04690

Healthcare professional-administered intra-articular injection performed once on Day 1 of the study.

Trial Locations (1)

94158

Research Site, San Francisco

Sponsors
All Listed Sponsors
lead

Biosplice Therapeutics, Inc.

INDUSTRY